A Disintegrin and Metalloproteinase with Thrombospondin Motifs (ADAMTS) is a family of zinc-dependent enzymes that participate in the degradation and remodeling of the extracellular matrix (ECM). ADAMTS-14 is a specific member of this family, sharing its canonical structure that includes a metalloproteinase domain, a disintegrin-like domain, and thrombospondin type 1 repeats. Similar to other family members, ADAMTS-14 is involved in the cleavage of large ECM proteins, including but not limited to aggrecan, versican, and fibronectin. The regulation of ADAMTS-14 activity involves various mechanisms like transcriptional control, post-translational modifications, and interactions with endogenous inhibitors. Factors such as growth factors, cytokines, and oxidative stress can influence the expression and function of ADAMTS-14, thereby shaping the composition and stability of the ECM.
ADAMTS-14 Activators can enhance the activity or expression of ADAMTS-14, either directly or indirectly. Various signaling cascades and regulatory mechanisms can be targeted to achieve this activation. For example, molecules that inhibit pathways known to downregulate ADAMTS-14 expression could serve as indirect activators. Epigenetic modulators, such as histone deacetylase (HDAC) inhibitors, could also facilitate increased gene expression of ADAMTS-14. Another route to activation could involve the stabilization of the ECM by molecules like lysyl oxidase inhibitors, thereby preserving the natural substrates of ADAMTS-14 for cleavage. Small molecules that reduce oxidative stress might also contribute to optimal enzyme function. Collectively, these activators operate through a complex web of biological pathways to modulate ADAMTS-14 activity, ultimately impacting ECM structure and function.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
A TGF-β inhibitor that could upregulate ADAMTS-14 by suppressing signaling pathways that may downregulate its expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
An HDAC inhibitor that could facilitate ADAMTS-14 gene expression by altering the epigenetic landscape. | ||||||
GM 6001 | 142880-36-2 | sc-203979 sc-203979A | 1 mg 5 mg | $77.00 $270.00 | 55 | |
An MMP inhibitor that could maintain the ECM substrates available for ADAMTS-14 activity, thus potentially indirectly activating it. | ||||||
3-Aminopropionitrile | 151-18-8 | sc-266473 | 1 g | $104.00 | ||
These could stabilize the ECM, affecting the substrate availability for ADAMTS-14. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
A PDGF Small Molecule Inhibitor that could influence ADAMTS-14 activity by interfering with growth factor-mediated ECM remodeling. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
An Nrf2 activator that could affect ADAMTS-14, particularly under conditions of oxidative stress. | ||||||
Dimethyloxaloylglycine (DMOG) | 89464-63-1 | sc-200755 sc-200755A sc-200755B sc-200755C | 10 mg 50 mg 100 mg 500 mg | $84.00 $301.00 $374.00 $779.00 | 25 | |
A hydroxylase inhibitor that might modulate post-translational modifications affecting the stability or activity of ADAMTS-14. | ||||||
N-Acetyl-L-cysteine | 616-91-1 | sc-202232 sc-202232A sc-202232C sc-202232B | 5 g 25 g 1 kg 100 g | $34.00 $74.00 $270.00 $114.00 | 34 | |
As a reactive oxygen species (ROS) scavenger, this molecule could potentially activate ADAMTS-14 by reducing oxidative stress that may impair its activity. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
A gamma-secretase inhibitor that interferes with Notch signaling could indirectly affect ADAMTS-14 expression or activity. | ||||||